FRED ALGER MANAGEMENT, LLC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 3520 NEW YORK, NY

Position in CLDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$351,560

-$233,800 QoQ

Shares Held

9,448

-48.8% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#158

of 252 holders

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FRED ALGER MANAGEMENT, LLC holds $748,337,711 across 53 Biotechnology names. CLDX ranks #47 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	3,301,919	$269,139,417
2	DNTH	Dianthus Therapeutics, Inc. /DE/	1,302,493	$126,967,017
3	RVMD	Revolution Medicines, Inc.	259,468	$48,593,167
4	ASND	Ascendis Pharma A/S	171,447	$45,728,343
5	COGT	Cogent Biosciences, Inc.	1,072,830	$41,518,521
6	ROIV	Roivant Sciences Ltd.	1,081,421	$38,271,489
7	FBRX	Forte Biosciences, Inc.	1,439,697	$30,593,561
8	ERAS	Erasca, Inc.	1,308,455	$23,970,895

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$351,560	9,448	-48.8%	Shares	Sole	2026-08-14
2026-03-31	$585,360	18,454	-88.8%	Shares	Sole	2026-05-15
2023-06-30	$5,609,205	165,317	-54.6%	Shares	Sole	2023-08-14
2023-03-31	$13,106,542	364,273	-30.1%	Shares	Sole	2023-05-16
2022-12-31	$23,215,265	520,872	+17.4%	Shares	Sole	2023-02-14
2022-09-30	$12,470,776	443,642	+82.3%	Shares	Sole	2022-11-15
2022-06-30	$6,561,605	243,383	+56.2%	Shares	Sole	2022-08-15
2022-03-31	$5,306,684	155,804	-69.0%	Shares	Sole	2022-05-16
2021-12-31	$19,402,110	502,125	-4.5%	Shares	Sole	2022-02-14
2021-09-30	$28,391,559	525,867	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.